WARSAW, Ind., Nov. 8, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will participate in the Evercore ISI HealthCONx Conference at the Four Seasons Hotel in Boston. Suky Upadhyay, Executive Vice President and Chief Financial Officer

TAMPA, Fla., Nov. 8, 2019 /PRNewswire/ -- Ultimate Medical Academy (UMA) maintained its strong support for the Women's Conference of Florida for the third consecutive year, serving as both a sponsor of the Nov. 1 main event and a presenting organization at the College Women on the Rise program, which took pla

CAMBRIDGE, Mass., Nov. 8, 2019 /PRNewswire/ -- Torque, a clinical-stage immuno-oncology company developing Deep Primed™ T cell immunotherapy to direct immune power deep within the tumor microenvironment, announced today new preclinical data for its lead Deep IL-15 Primed T cell, Deep Il-12 Primed T cell, and Deep TLR Primed T cell therapeutics programs as well as f

CHICAGO, Nov. 8, 2019 /PRNewswire/ -- Hillrom (NYSE: HRC) announced today that its board of directors declared a fiscal 2020 first quarter dividend of $0.21 per share payable on December 31, 2019, to shareholders of record as of the close of business on December 16, 2019. The indicated annual dividend rate is

INDIANAPOLIS, Nov. 8, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it will present new data from Taltz® (ixekizumab) and Olumiant® (baricitinib) at the American College of Rheumatology (ACR)/Association of Rheumatology Professionals (ARP) annual meeting taking place Nov. 8-13, 2

STAINES-UPON-THAMES, United Kingdom, Nov. 8, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, will present at the Jeffer

NORTH CHICAGO, Ill., Nov. 8, 2019 /PRNewswire/ -- In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. confirms that as of November 6, 2019 its issued share capital, excluding treasury shares, is comprised of 1,478,830,254 shares of common stock with a par value of $

LUND, Sweden, Nov. 8, 2019 /PRNewswire/ -- BioInvent International AB (publ) (OMXS: BINV) today announces it will make a poster presentation with preclinical data on BI-1206 at the annual American Society of Hematology (ASH) meeting in Orlando, Florida held December 7-10. The abstract, published

CAMBRIDGE, England and BOSTON, Nov. 8, 2019 /PRNewswire/ -- Abcam plc, a global innovator in life science reagents and tools, is today pleased to announce a strategic partnership with BrickBio, experts in site-specific protein modification and a Tiger Gene portfolio company, covering the use of BrickBio's proprietary platform for introducing conjugation-ready sites

WINDSOR LOCKS, Conn., Nov. 8, 2019 /PRNewswire/ -- Internet conference information is at:  http://ritualabuse.us/smart-conference/ Complimentary l